Journal Article10.1016/j.addr.2022.114357
Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment.
38
TL;DR: In this article , a review on the pathological hallmarks of pancreatic ductal adenocarcinoma (PDAC) and the impact of nanotechnology to find solutions is presented.
read more
About: This article is published in Advanced Drug Delivery Reviews. The article was published on 01 May 2022. The article focuses on the topics: Medicine & Pancreatic cancer.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Two-Stage SN38 Release from a Core–Shell Nanoparticle Enhances Tumor Deposition and Antitumor Efficacy for Synergistic Combination with Immune Checkpoint Blockade
TL;DR: In this paper , a two-stage release strategy was proposed to enhance the drug deposition and antitumor efficacy of OxPt/SN38 core-shell nanoparticles with a hydrophilic oxaliplatin (OxPt) prodrug coordination polymer core and a lipid shell containing a cholesterol-conjugated SN38 prodrug (Chol-SN38).
42
Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy.
Youyou Li,Jing Liu,Yimei Chen,Ralph R Weichselbaum,Wenbin Lin +4 more
TL;DR: Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy by enhancing immunogenic cell death and promoting T cell infiltration.
33
miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance.
Reem K. Shahin,Mohamed Amr Elkady,Ahmed I. Abulsoud,Nourhan M. Abdelmaksoud,Sherif S. Abdel Mageed,Walaa A. El-Dakroury,M. Zewail,Mohamed H. Sobhy,Yousra Nomier,Ola Elazazy,Mohammed S. Elballal,Osama A. Mohammed,Heba M. Midan,Mahmoud Ahmed Elrebehy,Ahmed S. Doghish +14 more
TL;DR: Embryonic miRNAs have the potential to serve as valuable biomarkers and therapeutic targets for GBC.
31
Theranostics applications of quantum dots in regenerative medicine, cancer medicine, and infectious diseases.
TL;DR: In this paper , the frontiers of diagnostic and therapeutic applications (theranostics) of QDs, especially in advanced medical fields such as regenerative medicine, oncology, and infectious diseases, are outlined.
23
Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer
TL;DR: The overview illustrates the significant advances in nanomedicine, underscoring its role in transcending the constraints of conventional PDAC therapies and diagnostics.
15
References
Targeting the premetastatic niche: epigenetic therapies in the spotlight.
TL;DR: Using three syngeneic mouse models of aggressive lung metastasis, Lu and colleagues show that MDSCs accumulate in the lung PMN and contribute to metastasis formation after primary tumors resection, and propose a novel therapeutic avenue to supplement tumor resection.
Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin.
Wei Chen,Yue Zhou,Xiao Zhi,Tao Ma,Hao Liu,Brayant Wei Chen,Xiaoxiao Zheng,Shang-Zhi Xie,Bin Zhao,Xin-Hua Feng,Xiaowei Dang,Tingbo Liang +11 more
TL;DR: A new chimeric peptide (PL-1) composed of plectin-1-targeted PDAC-specific and arginine-rich RNA-binding motifs which could condense miRNA to self-assemble supramolecular nanoparticles is developed and identified miR-212/USP9X as a new potential target for future systemic therapy against human PDAC.
Gemcitabine Combination Nano Therapies for Pancreatic Cancer.
TL;DR: The focus on novel mucin-targeted nanotechnology which is under development for pancreatic cancer therapy is documents, focusing on how nanocarriers have been fabricated, and the differences in the physiological environment where the targeting is to be done.
Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy
Xiaofei Xin,Virender Kumar,Feng Lin,Vinod Kumar,Rajan Sharma Bhattarai,Vijaya Raj Bhatt,Chalet Tan,Ram I. Mahato +7 more
TL;DR: In this article, the authors demonstrated that miR-519c was downregulated in pancreatic cancer and transfection of miR519c in GEM-resistant pancreatic cells inhibited HIF-1α level under hypoxia.